EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clinical Utility of Far‐Field Potentials in Amyotrophic Lateral Sclerosis

Aicee Dawn Calma, Nathan Pavey, Claudia Santos Silva iD, Yukiko Tsuji iD, Mehdi A J Van den Bos, Michelle A Farrar iD, Parvathi Menon iD, Steve Vucic iD

Muscle & Nerve · 2025

DOI: 10.1002/mus.28480 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscle & Nerve, 2025. Verfasst von Aicee Dawn Calma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Brain and Nerve Research Centre, Concord Clinical School, University of Sydney, Concord Hospital, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Ulnar Nerve, Action Potentials. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims Far field potentials (FFP) have been proposed as a reliable neurophysiological prognostic biomarker in amyotrophic lateral sclerosis (ALS). This study evaluates the diagnostic utility of ulnar nerve FFP in ALS.

Methods

Comprehensive peripheral neurophysiological assessments were conducted in 62 ALS and 43 ALS‐mimicking disorder participants. The ulnar nerve was stimulated at the wrist, recording motor responses over the abductor digit minimi (ADM) muscle. Conventional compound muscle action potentials (CMAP), FFP, and near field potential amplitudes were recorded, alongside the split‐hand index, neurophysiological index, motor unit number estimation (MScanFit‐MUNE), and motor unit index (MUNIX). Diagnostic utility was evaluated using receiver operating characteristic (ROC) analysis.

Results

In ALS, FFP amplitude was significantly lower (5.07 ± 0.36 mV) compared to ALS mimics (8.25 ± 0.40 mV, p < 0.001). FFP amplitude exhibited a moderate‐to‐strong correlation with neurophysiological biomarkers, including CMAP amplitude ( ρ = 0.77, p < 0.001), split‐hand index ( ρ = 0.53, p < 0.001), neurophysiological index ( ρ = 0.52, p < 0.001), MUNIX ( ρ = 0.69, p < 0.001), and MScanFit‐MUNE ( ρ = 0.66, p < 0.001). Weak‐to‐moderate correlations were also observed with clinical measures of disease progression, including upper limb muscle strength, ALS functional rating score‐revised (ALSFRS‐R) and the rate of decline in the ALSFRS‐R fine motor subscore. ROC analysis demonstrated that FFP amplitude reliably distinguished ALS from mimicking disorders (AUC = 0.80, 95% CI: 0.71–0.89), with consistent diagnostic accuracy across ALS phenotypes.

Discussion

The diagnostic capability of FFP amplitude was comparable to established neurophysiological biomarkers utilized in ALS. It is a promising prognostic and diagnostic biomarker for ALS. Its simplicity and reproducibility complement traditional neurophysiological measures, offering potential for clinical application in ALS diagnosis and monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisUlnar NerveAction PotentialsHumansMaleMiddle AgedFemaleAgedAdultElectromyographyMuscle, SkeletalROC CurveNeural Conduction

Stichwörter der Autor:innen

CMAPamyotrophic lateral sclerosisfar‐field potentialnear‐field potential

Autor:innen und Institutionen

  • Brain and Nerve Research Centre, Concord Clinical School, University of Sydney, Concord Hospital, Sydney, New South Wales, Australia.
  • Department of Neurosciences and Mental Health, Unidade Local de Saúde de Santa Maria, Lisbon, Portugal.
  • Faculdade de Medicina-Instituto de Medicina Molecular, Centro de Estudos Egas Moniz, Universidade de Lisboa, Lisbon, Portugal.
  • Department of Neurology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Department of Neurology, Sydney Children's Hospital Network, Sydney, New South Wales, Australia.
  • Discipline of Paediatrics and Child Health, School of Clinical Medicine, UNSW Medicine and Health, The University of New South Wales, Sydney, Australia.

ORCID-Profile: Claudia Santos Silva, Yukiko Tsuji, Michelle A Farrar, Parvathi Menon, Steve Vucic

Zitieren

APA

Calma, A. D., Pavey, N., Silva, C. S., Tsuji, Y., Van den Bos, M. A. J., Farrar, M. A., Menon, P., & Vucic, S. (2025). Clinical Utility of Far‐Field Potentials in Amyotrophic Lateral Sclerosis. Muscle & Nerve. https://doi.org/10.1002/mus.28480

Vancouver

Calma AD, Pavey N, Silva CS, Tsuji Y, Van den Bos MAJ, Farrar MA, et al. Clinical Utility of Far‐Field Potentials in Amyotrophic Lateral Sclerosis. Muscle & Nerve. 2025. doi:10.1002/mus.28480

BibTeX
@article{Calma2025,
  author = {Calma, Aicee Dawn and Pavey, Nathan and Silva, Claudia Santos and Tsuji, Yukiko and Van den Bos, Mehdi A J and Farrar, Michelle A and Menon, Parvathi and Vucic, Steve},
  title = {Clinical Utility of Far‐Field Potentials in Amyotrophic Lateral Sclerosis},
  journal = {Muscle & Nerve},
  year = {2025},
  doi = {10.1002/mus.28480}
}
Kostenlos starten →